In this issue:
The significance of positive direct antiglobulin test in CLL
Nilotinib is active in patients with imatinib-resistant or
-intolerant accelerated-phase CML
High incidence of avascular necrosis in adolescents with ALL
Genetically identical twin transplantation for CLL
Erlotinib exhibits antineoplastic off-target effects in AML and MDS
Subcutaneous panniculitis-like T-cell lymphoma
Bortezomib and inducing apoptosis of mantle cell lymphoma cells
Central nervous system relapse in aggressive NHL
Extended treatment with rituximab in patients with post-transplant
lymphoproliferative disease
Reduced-intensity conditioning or myeloblative
conditioning in relapsed or refractory Hodgkin’s lymphoma
Please login below to download this issue (PDF)